Showing results (1-10 of 225) with videos related to
Sort By:
Pageof 23
Critical Reviews in Immunology|November 19, 2010
A CCL2-based fusokine as a novel biopharmaceutical for the treatment of CCR2-driven autoimmune diseasesMoutih Rafei, Jacques GalipeauMolecular Therapy : the Journal of the American Society of Gene Therapy|July 16, 2009
Allogeneic mesenchymal stem cells for treatment of experimental autoimmune encephalomyelitisMoutih Rafei, Elena Birman, Kathy Forner, et al.Blood|November 4, 2006
A GMCSF and IL-15 fusokine leads to paradoxical immunosuppression in vivo via asymmetrical JAK/STAT signaling through the IL-15 receptor complexMoutih Rafei, Jian Hui Wu, Borhane Annabi, et al.Molecular Therapy : the Journal of the American Society of Gene Therapy|December 18, 2008
Mesenchymal stromal cells engineered to express erythropoietin induce anti-erythropoietin antibodies and anemia in allorecipientsPhilippe M Campeau, Moutih Rafei, Moïra François, et al.Blood|July 10, 2009
Characterization of Gaucher disease bone marrow mesenchymal stromal cells reveals an altered inflammatory secretomePhilippe M Campeau, Moutih Rafei, Marie-Noëlle Boivin, et al.Molecular Therapy : the Journal of the American Society of Gene Therapy|July 5, 2012
Inducible IL10(+) suppressor B cells inhibit CNS inflammation and T helper 17 polarizationJeremy Hsieh, Patrick Williams, Moutih Rafei, et al.Molecular Therapy : the Journal of the American Society of Gene Therapy|April 16, 2009
Autologous bone marrow stromal cells genetically engineered to secrete an igf-I receptor decoy prevent the growth of liver metastasesNi Wang, Lucia Fallavollita, Long Nguyen, et al.Journal of Immunology (Baltimore, Md. : 1950)|February 24, 2009
Selective inhibition of CCR2 expressing lymphomyeloid cells in experimental autoimmune encephalomyelitis by a GM-CSF-MCP1 fusokineMoutih Rafei, Philippe M Campeau, Jian Hui Wu, et al.Molecular Therapy : the Journal of the American Society of Gene Therapy|April 15, 2010
A fusion of GMCSF and IL-21 initiates hypersignaling through the IL-21Ralpha chain with immune activating and tumoricidal effects in vivoPatrick Williams, Moutih Rafei, Manaf Bouchentouf, et al.Journal of Immunology (Baltimore, Md. : 1950)|July 14, 2009
An engineered GM-CSF-CCL2 fusokine is a potent inhibitor of CCR2-driven inflammation as demonstrated in a murine model of inflammatory arthritisMoutih Rafei, Yamina A Berchiche, Elena Birman, et al.Pageof 23